共 77 条
[1]
Freifeld AG(2011)Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America Clin Infect Dis 52 e56-e93
[2]
Bow EJ(2009)Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology Haematologica 94 113-122
[3]
Sepkowitz KA(2011)Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation Br J Haematol 155 318-327
[4]
Cornely OA(2016)Newer antifungal agents micafungin and voriconazole for fungal infection prevention during hematopoietic cell transplantation: a meta-analysis Euro Rev Med Pharmacol Sci 20 381-390
[5]
Bohme A(2014)Mixed treatment comparison of prophylaxis against invasive fungal infections in neutropenic patients receiving therapy for haematological malignancies: a systematic review J Antimicrobial Chemother 69 1-11
[6]
Buchheidt D(2007)Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study BMC Infect Dis 7 70-667
[7]
Marks DI(2010)Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHD Bone Marrow Transplant 45 662-638
[8]
Pagliuca A(2014)Comparison of itraconazole, voriconazole, and posaconazole as oral antifungal prophylaxis in pediatric patients following allogeneic hematopoietic stem cell transplantation Eur J Clin Microbiol Infect Dis 33 629-503
[9]
Kibbler CC(1993)Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial Ann Intern Med 118 495-449
[10]
Xu SX(2007)A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML) J Infect 55 445-340